S in the active(88.0) Serum L-arginine, 175.0 (93.1) 170.six group(222.8 (88.6) ) body mass index; ICU

S in the active(88.0) Serum L-arginine, 175.0 (93.1) 170.6 group(222.8 (88.6) ) body mass index; ICU, to thosecarethe controlsexpressed as median (interquartile range) Abbreviations: BMI, had been comparable intensive of unit. Data are with no prior SARS-CoV-2 for continuous 0.eight). infection (p = variables and number (%) for categorical variables.Figure 2. Modifications from baseline to day 28 in serum -arginine levels within the two intervention Figure 2. Modifications from baseline to day 28 in serum LL-arginine levels in the two intervention groups. groups.L-arginine plus vitamin C supplementation was protected and well tolerated, and no adverse events were recorded. L-arginine plus vitamin C supplementation was protected and nicely tolerated, and no adverse events had been recorded. Efficacy EndpointsL Endpoints Efficacy-arginine plus vitamin C drastically elevated the distance walked on the 6 min walk test (median (IQR) adjust from baseline: +30.0 (40.five) m) compared with all the placebo L-arginine plus vitamin C substantially increased the distance walked on the six min (+0.0 (75.0) m; p = 0.001; mean distinction = 50 m, 95 CI: 20.00.0 m; effect size = 0.56) stroll test (median (IQR) transform from baseline: +30.0 (40.five) m) compared using the placebo (Figure three). (+0.0 (75.0) m; p = 0.001; imply difference = 50 m, 95 CI: 20.0-80.0 m; effect size = 0.56) (Figure three).Efficacy Endpoints plus vitamin C significantly elevated the distance walked on the six min walk test (median (IQR) alter from baseline: +30.0 (40.5) m) compared with the placebo 7 of 13 (+0.0 (75.0) m; p = 0.001; imply distinction = 50 m, 95 CI: 20.0-80.0 m; effect size = 0.56) (Figure 3).L-arginineNutrients 2022, 14,Figure 3. Adjustments from baseline to day 28 the 6 six min walk test distance the two intervention Figure 3. Alterations from baseline to day 28 inin the min walk test distance in in the two intervention groups. groups.Nutrients 2022, 14, 4984 8 of 14 At 28 days, L-arginine plus vitamin C supplementation induced greater improveAt 28 days, L-arginine plus vitamin C supplementation induced greater improvements in handgrip strength (+3.four (7.5) kg) compared using the placebo placebo kg, p = 0.03; mean ments in handgrip strength (+3.Lumiliximab MedChemExpress 4 (7.5) kg) compared with all the(+1.β-Cyclodextrin References 0 (six.PMID:24078122 6)(+1.0 (six.six) kg, p = difference difference = 3.four kg, 95 kg; impact size effect (Figure 4A). At baseline, about 0.03; mean = three.four kg, 95 CI: 0.5.4 CI: 0.5-9.4 kg; = 0.37)size = 0.37) (Figure 4A). At base60 of have been above the study had a handgrip a handgrip strength under the even though vs. 30 )the study from the initially quartile of handgrip strength reference25th percentile ofperline, around 60 participants participants had strength below the values [37], 25th ageand sex-specific reference groups did not reach the intervention, of intervention, the distinction and sex-specific reference values [37].statistical significance (p = 0.07).far more centile of age- amongst thevalues [37]. Just after 28 days ofAfter 28 days a lot more participants who received L-arginine dilation was C than these in C than these group (57 vs. 30 ) were Flow-mediated plus L-arginine plus vitamin the placebo within the L-arginine plus vitparticipants who receivedvitamingreater in participants who receivedplacebo group (57 above compared using the placebo strength reference values p = despite the fact that the distinction amin Cthe very first quartile of handgrip (14.3 (7.three) vs. 9.four (five.eight),[37], 0.03; imply difference = amongst the 0.4-6.5; impact reach the statistical significance (p = 0.07). three.4 ; 95 CI:gro.